SEC Form 4 · accession 0001144204-15-002279
Amarantus Bioscience Holdings, Inc. · AMBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Lewis Harris
Director
Period of report
Jan 12, 2015
Accepted (ET)
Jan 14, 2015 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424812
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2,F1 | $0.08 | Jan 12, 2015 | A | 600,000 | A | Jan 12, 2015 | Jan 12, 2025 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1Such shares shall vest in equal monthly installments beginning on the date of grant for a period of 48 months until it is entirely vested, subject to continued service with the Issuer.
- F2Granted to Reporting Person by the Issuer for services as a Director provided to the Issuer.